Inactive Instrument

Press Releases Imago BioSciences, Inc.

Equities

IMGO

US45250K1079

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Merck Completes Tender Offer to Acquire Imago BioSciences, Inc	12/01/23	AQ
Imago BioSciences : Acquisition/Asset Disposal - Form 8-K	11/01/23	PU
IMAGO BIOSCIENCES, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	11/01/23	AQ
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in Myelofibrosis	20/12/22	AQ
IMAGO BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/12/22	AQ
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022	12/12/22	AQ
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022	12/12/22	AQ
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia	30/11/22	AQ
IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO	23/11/22	BU
Merck to Acquire Imago BioSciences Inc	22/11/22	AQ
Carvana, Builders FirstSource fall; Disney, Imago rise	21/11/22	AQ
IMAGO BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	21/11/22	AQ
IMAGO BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/22	AQ
Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updates	09/11/22	AQ
Imago BioSciences to Participate in Upcoming Investor Conferences	07/11/22	AQ
Imago BioSciences Announces Oral Data Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition	03/11/22	AQ
Imago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference	06/09/22	AQ
IMAGO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	01/09/22	AQ
IMAGO BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	18/08/22	AQ
Imago BioSciences : Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates - Form 8-K	12/08/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Imago BioSciences, Inc.

Equities

IMGO

US45250K1079

Press Releases

Filters